附件99.3

本安防-半導體，以及本安防-半導體可行權的證券，並未在美國證券交易委員會或任何州證券委員會下注冊，依賴於《1933年證券法》修訂案（「證券法」）的註冊豁免，並且因此可能不得以除根據證券法項下生效的註冊聲明或根據現有的豁免，或在不受證券法註冊要求限制的交易中出售、質押，或以其他方式分配或轉讓，並且按照適用的州證券法，並且在每種情況下，公司與託管機構已經收到了理事會意見，對他們各自而言，表明此類交易不需要根據證券法註冊。

認購普通股權證書

以美國存託憑證代表

團車網有限公司

本授權證明書用於購買由美國存托股份代表的普通股份（以下簡稱「權限證書」），證明[_____________]或其受讓人（以下簡稱「持有人」）有權根據下文約定的條款和條件，在此之後的任何時間（「初始行權日期」）和初始行權日期五（5）年週年紐約時間下午5:00（「終止日期」）之前但不得以後，向團車網有限公司（以下簡稱「公司」），訂閱併購買至多[______]普通股份（以下簡稱「權限股份」），由[_____]美國存托股份代表（「ADS」）所代表，如根據下文調整（「權限ADS」）。本許可證下的一份權限ADS的購買價格應等於行權價格，如第2（b）條所定義。

衝突礦物披露。. 定義。 本協議中使用但未另行定義的大寫字詞應具有《證券購買協議》中規定的含義，該協議日期爲2024年[__年__月__日]，由公司和簽署人簽署。

第2節. 行權.

a) 行權 權證行使本權證所代表的購買權可以在初始行使日期之後的任何時間全部或部分行使，在終止日期之前通過電子郵件（或電子郵件附件）提交一份正式執行的PDF副本格式的行使通知（以下簡稱「行使通知」）提交給公司。在如上述行使日期之後兩個（2）個交易日內且標準結算期（在本部分2(d)(i)中定義）所包括的交易日數量之內的後一個，持有人應當通過電匯或抽頭支票畫在美國銀行上支付購買並在適用的行使通知中規定的權證ADSs的行使價。除非適用的行使通知中規定了下文2(c)節指定的無現金行使程序，否則不需要提供原件行使通知，也不需要提供任何鋼印擔保（或其他類型的擔保或公證）的行使通知。儘管本文件中有任何相反規定，持有者不需要在購買所有在此可用的權證ADSs的權證之前將本權證實物交還給公司，並且權證被全部行使後，持有者應當在有關公司收到最終行使通知之後儘快將本權證交還給公司予以註銷。行使本權證部分導致購買本權證下可用的全部權證ADSs的情形將導致削減本權證下可購買的權證ADSs的未償餘額數額等於已購買的權證ADSs的數量。持有者和公司應當保留顯示已購買的權證ADSs數量和購買日期的記錄。公司應當在收到任何通知後的一個（1）個工作日內提出任何異議。 持有人和任何受讓人在接受本權證時，承認並同意，由於本段的規定，購買本文所述的一部分權證ADS之後，任何給定時間可購買的權證ADS數量可能會小於本權證正面所述的金額。

b) 行使價格根據本授予證書第2(c)條的規定，本認股權證每個ADS的行使價格爲$[___]，根據本約定進行調整 （「行使價格」）。

c) 無現金行權如果在距離認股權證初始發行日後6個月後的日期，在此行使時 持有人尚未有有效的註冊聲明書，也沒有可供其轉售認股權證股票的現行招股說明書可用，則認股權證 在此時也可全數或部分行使，以「無現金行使」方式，持有人有權收到認股權ADS數量，其計算方法爲[(A-B) (X)]除以(A)，其中:

(A) = 根據具體情況： （i）如果這樣的行權通知書日期的前一個交易日的成交量加權平均價格等於適用的通知書（1）根據本約定的第2(a)部分執行和送達的交易日，但不是交易日，或（2）根據本約定的第2(a)部分在交易日「正規交易時間」（根據聯邦證券法規NMS規則600(b)(68)下發布的規定）之前執行和送達的，或者根據Bloomberg L.P.（「Bloomberg」）報告的ADSs在主要交易市場的最高買盤價格在持有人執行適用的行權通知的時間時（如果這樣的行權通知在交易日「正規交易時間」內執行並在之後兩個小時內交付（包括在交易日「正規交易時間」結束後兩小時內）根據本約定的第2（a）部分或（iii）如果這樣的行權通知書的日期是一個交易日並且這樣的行權通知書是在該交易日的「正規交易時間」結束後根據本約定的第2(a)部分執行和送達的，則爲適用行權通知書日期的成交量加權平均價格；

(B) = 根據此處進行調整的本認股證的行權價格；和

(X) = 根據這個認股權協議的條款行使選項時由認購人承購的認股ADS的數量，如果該行權是以現金行權而不是無現金行權。

如果認股權ADS以無現金行使而發行，則各方承認並同意，根據證券法第3(a)(9)條的規定，正在發行的認股權ADS的持有期可能會附加到本認股權的持有期。公司同意不採取任何與本2(c)部分相悖的立場。

“買盤價” 意味着，對於任何日期，根據適用的以下第一個條款確定的價格：(a) 如果此時ADS在交易市場上報價或上市，則根據Bloomberg報告的該交易市場上ADS的買盤價格（基於紐約時間上午9:30到下午4:02之間的交易日）的時間價格（或最近的前一個日期），(b) 如果OTCQb或OTCQX不是交易市場，則適用當日（或最近的前一個日期）在OTCQb或OTCQX的ADS的成交量加權平均價格，(c) 如果此時ADS未在OTCQb或OTCQX上報價或交易，且如果ADS的價格是在The Pink Open Market（或類似接替其價格報告功能的組織或機構）上報告的，則根據該報告的ADS每股買盤價格中最近的報價，或(d) 在所有其他情況下，由優先持有該時期尚未清償的證券大部分利益的持有人善意選擇的獨立評估師確定的一個ADS的公允市場價值，該評估師的費用和開支應由公司支付。

“「VWAP」表示任何日期上任何證券的美元成交量加權平均價格，在納斯達克資本市場（或如果納斯達克資本市場不是該證券的主要交易市場，那麼在該證券的主要證券交易所或證券市場上，在該證券上從美國東部時間上午9:30開始，到美國東部時間下午4:00結束，在該證券上由彭博社通過其「VAP」功能報告的美元成交量加權平均價格(設置爲9:30開始時間和16:00結束時間)；如果上述情況不適用，則爲在該證券的場外市場上，該證券的電子公告板在美國東部時間上午9:30開始，到美國東部時間下午4:00，在彭博社報告的美元成交量加權平均價格，或者如果沒有任何市場商報告該證券的美元成交量加權平均價格，則該證券市場製造商的最高收盤買入價與最低收盤賣出價的平均值從The Pink Open Market（或類似的機構或代理機構繼承其報告價格的功能）或其他方式獲得。如果無法計算該日期上該安全的VWAP，則該日期上該安全的VWAP將是我們和債券持有人共同確定的公平市場價值。如果我們和債券持有人無法就該證券的公平市場價值達成一致意見，那麼這種爭議應根據條款中規定的程序解決。對於所有這些決定應適當調整任何股票股利、股票分割、股票組合、資本重組或其他類似交易的加權平均價格。”表示，對於任何日期，由適用的以下條款中首先適用的條款決定的價格：(a)如果ADS隨後在交易市場上市或報價，ADS的當日成交量加權平均價格(或最接近的前一日期)將由彭博有限合夥公司報告，作爲ADS當前上市或報價的交易市場的當日成交量加權平均價格(基於紐約市時間上午9:30至下午4:02的交易日時間)，(b)如果OTCQB創業公司市場("OTCQB")或OTCQX最佳市場("OTCQX")不是交易市場，則ADS的當日成交量加權平均價格(或最接近的前一日期)將由OTCQB或OTCQX適用，(c)如果ADS當時未在OTCQB或OTCQX上市或報價進行交易，且ADS價格正在由OTC Markets，Inc.運營的粉紅開放市場("粉紅市場")或類似機構或組織以其報告價格的職能繼任者報告，則按照每股ADS的最近報價報告的最近出價價格，或(d)在其他所有情形下，ADS的公允市場價值將由一家獨立評估師以誠信和合理地由當時未償還的證券權益的持有方擇定並得到公司合理接受來確定，該評估師的費用和支出將由公司支付。

除非有相反規定，否則在終止日期，本認股權將通過免現金行使根據本第2(c)條自動行使。

d) 鍛鍊的機理.

i. 在行使權證ADS時交付公司應導致在此處購買的認股權證股份通過美國紐約銀行梅隆銀行（以下簡稱「銀行」），代表ADS的存託人（下稱「存託人」）通過將認股權證股票的數量記入持有人或其指定的帳戶的存託人信託公司的存款或提取保管員系統（「DWAC」）向持有人發送，如果公司那時是該系統的參與者並且（A）存在有效的註冊聲明允許向認股權證股票持有人發行或轉售認股權證ADS所代表的認股權證股份或（B）認股權證ADS所代表的認股權證股份對持有人無成交量或銷售方式限制適用於《144條例》（假定對認股權證的無現金行使），否則通過向持有人在行使通知中指定的地址交付一份註冊在公司的股份登記冊上以持有人或其指定的名字持有持有人有資格根據行使取得的認股權證股份數交付的證書的物理交付，到達公司收到行使通知之後的（i）交易日和（ii）標準結算期間交付完整行使價格（除非以無現金行使方式）的最晚日期 (以下簡稱「認股權證ADS交付日期」)，在此日期之前，在此日期之前，提供了與行使相關的概括性行使價格（除非以無現金行使方式）並收到該認股權ADS交付日期（如果此類概括性行使價格（除非以無現金行使方式）未在此日期之後交付，認股權證ADS交付日期應爲交付完整行使價格之後的兩個（2）個交易日），在交付行使通知後，公司將在所有公司目的上將該持有人視爲認股權證ADS的認股權證股份的有利所有者截至行使認股權證的日期，無視認股權證ADS的交付日期，前提是最晚在行使通知交付後的（i）兩（2）個交易日和（ii）交付通知後的標準結算期間內的交易日數。 如果基於任何理由存託人未在認股權證ADS交付日期前交付給持有人與認股權證通知相關的認股權證ADS，公司應支付給持有人現金，作爲已達成的賠償，而不是作爲處罰，每一$1,000的認股權證ADS受到此類行使的影響（以ADS的VWAP爲基礎稅後的VWAP通告發布日期），每個交易日支付$10（從將認股權證ADS交付日期後第三個交易日增加爲每個交易日的$20），直到認股權證ADS交付或持有人撤消該等行使。如用於此處，「標準結算期間」 表示在公司主要交易市場的標準結算期間，以交易日數表示，即在行使通知交付日期生效。

ii. 行使期權時，發行新的期權 。如果本期權被部分行使，公司應在持有人的請求和本期權證書的交割時，交付給持有人一份新的期權證明持有人購買本期權未購買的股票的權利，該新期權在其他方面與本期權完全相同。如果這份認股權證已經部分行使，公司應在持有人的要求並在交付認股權證ADS時交出這份認股權證，交付給持有人一份新的認股權證，證明持有人有權購買此認股權證要求購買但尚未購買的認股權證ADS，此新認股權證在其他方面應與本認股權證完全相同。

iii. 撤銷 權利.如果公司未能導致託管機構在Warrant ADS交付日期前按照2(d)(i)款向持有人交付Warrant ADS，則持有人有權撤銷對未傳輸的Warrant ADS的行使（使得持有人根據本認股權證取得這些未傳輸的Warrant ADS的權利得以恢復），公司應當返還給持有人爲這些未傳輸的Warrant ADS向公司支付的總行權價格的部分。

iv. 補償 因未能及時交付認購權證ADS而引起的買入除了持有人享有的其他權利外，如果存託人未能根據上述第2(d)(i)款的規定在權證ADS交割日期之前根據行使要求向持有人交付權證ADS，並且在該日期之後，持有人被其券商要求購買（在開放市場交易或其他方式中）或者持有人的券商以其他方式購買ADS以滿足持有人預期在此類行使時獲取的出售由持有人的權證ADS所需，那麼公司應（A）向持有人支付現金金額，如有任何的話，即（x）持有人購買此類ADS的總價格（包括佣金，如果有的話）超出（y）通過將產生此類購買義務的賣出訂單執行價格乘以（1）公司未能交付給持有人的與有關行使有關的權證ADS數量和（2）執行該購買義務的價格之間的金額，和（B）由持有人選擇，要麼恢復關於相應數量的未獲得行使的權證中的部分，並退還公司在對應的權證ADS的行使價格方面收到的任何金額（在這種情況下，此類行使將被視爲被撤銷），或者向持有人交付會在公司及時履行其在此文件中的行使和交付義務時發行的ADS數。例如，如果持有人購買總價值爲$11,000的ADS以覆蓋涉及總銷售價格爲$10,000的嘗試行使權證所導致的購買義務，根據上述句子的第（A）條款，公司將需支付給持有人$1,000。持有人應向公司提供書面通知，指示應向持有人支付的購買金額，且在公司的請求下，應提供損失金額的證據。本文件中的任何條款均不限制持有人根據法律、法律、特約執行的裁定和/或關於公司未能按照此處規定的條款要求及時交付ADS的行使權等其他救濟的權利。

v. 不發行碎股或認股權證ADSs在行使本認股權證時不會發行任何認股權證ADSs的碎股。 關於持有人本應在行使中獲得購買的ADS的任何部分，公司可選擇 以等於該部分乘以行使價格的金額支付現金調整，或者 將其上調至下一個整數ADS；但是，如果將ADS的部分上調至下一個整數ADS導致發行價格低於ADS的票面價值，則不得進行上調。

vi. 收費、稅費和費用發行認股權證ADS應當無需向持有人收取任何發行或轉讓稅或其他雜費，所有這些稅款和費用應由公司支付，並且應將該認股權證ADS以持有人的名義或持有人指定的名義發行；但前提是，如果認股權證ADS將以非持有人名義發行，則行使時應連同持有人簽署並執行的附表一《指定書》一併交付，公司可能要求作爲控件條件支付足以償還任何與此相關的過戶稅的款項。公司應支付因發行認股權證ADS而必須支付的所有與其同日電子發行和交付認股權證ADS以及發行本合同下認股權證ADS所涉定存機構的所有相關費用和支出。

vii. 結賬 公司不會以任何方式關閉其股東登記簿或檔案，從而阻止及時行使本認股權證，根據本協議的條款；但是，前述不得被視爲或解釋爲限制託管人根據包括但不限於公司和託管人之間的存託協議的條款和規定享有的任何權利。

e) 持有人的行使限制儘管本文件中包含任何相反的內容，公司不得行使此認股權證，持有人也沒有權利根據第2條或其他規定行使此認股權證的任何部分，因爲在進行行使後發行的效果如適用的行使通知中所規定，持有人（連同持有人的關聯公司和任何作爲一組與持有人或其中任何持有人的關聯方一起行動的其他人（這些人稱爲「歸屬方」））將獲得對受益擁有的普通股超過受益擁有限制（如下所定義）。 對於上述句子，持有人及其關聯公司和歸屬方擁有的普通股數量將包括持有人是否擁有以下此認股權證可行使ADSs的普通股數量，但將不包括持有人或其關聯公司或歸屬方擁有的尚未行使的認股權證剩餘部分或任何其他公司證券的尚未行使或未轉換部分的普通股數量（包括但不限於任何其他普通股等效證券），該公司證券受限於與本規定類似的轉換或行使限制，並由持有人或其關聯公司或歸屬方擁有。 除前述句子規定外，在本第2條(e)節目的目的，受益擁有將根據《證券交易法》第13(d)節和在其下制定的規則及法規進行計算，持有人事先承認公司沒有向持有人表示此計算符合《證券交易法》第13(d)節的規定，持有人將全部負責根據其進行需要提交的安排。 如本第2條(e)節中所述的限制適用，本認股權是否可行（相對於任何合作方共同擁有的其他公司證券）以及這本認股權的哪部分可行應該由持有人自行決定，並提出行使通知應被視爲持有人決定此認股權是否可行（就其他公司證券而言，這些公司證券是由持有人連同任何關聯方和歸屬方共同擁有的）和此認股權的哪部分可行，每種情況均受益擁有限制的約束，公司無需驗證或確認此等決定的準確性。 此外，如上面所設想的任何團體身份的確定應根據《證券交易法》第13(d)節和隸屬機構頒佈的規則和規定進行確定。 爲本第2條(e)節目的目的，在決定普通股的未被聲明的數量時，持有人可以依賴於（A）公司最近的在美國證券交易委員會提交的20-F表格、6-k報告或其他公開申報，（B）公司更近期的公開聲明或（C）公司或託管人發出的更近期的書面通知傳達的普通股數量。 在持有人的書面或口頭要求後，該公司應於一（1）個交易日內向持有人口頭和書面確認普通股的數量。 在交易日後，持有的一方或其關聯公司或歸屬方進行的公開公告以及持有的一方披露的截至至此前述普通股數量以來進行的公司證券轉換或行使後，將由現有普通股數量確定。 「受益擁有限制」將是[4.99%][9.99%]，即使新發行股票後的人均普通股數。 持有人在通知公司後，可以增加或減少本第2條(e)節的受益擁有限制條款，但任何情況下，受益擁有限制不得超過新發行普通股的9.99%的普通股數量，轉換或行使此認股權證後由持有方持有，本第2條(e)的相關規定將繼續適用。 任何關於受益擁有限制增加的聲明將在遞交給公司後第61天方能生效。 本段規定將被解釋和執行，以非嚴格遵守本第2條(e)節的條款的方式，以更正或修改此合理所有權限制內所含有的本段（或本段任何部分）可能有缺陷或與預期的受益所有權限制不一致的地方，或進行必要或理想的更正或補充以正確地給予此類限制效力。 本段中包含的限制將適用於此認股權的繼任持有人。

Section 3. Certain Adjustments.

a) Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a share dividend or otherwise makes a distribution or distributions on shares of its ADSs or Ordinary Shares or any other equity or equity equivalent securities payable in ADSs or Ordinary Shares (which, for avoidance of doubt, shall not include any Ordinary Shares or ADSs issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding Ordinary Shares or ADSs into a larger number of Ordinary Shares or ADSs, as applicable, (iii) combines (including by way of reverse share split) outstanding ADSs or Ordinary Shares into a smaller number of Ordinary Shares or ADSs, as applicable, or (iv) issues by reclassification of ADSs, Ordinary Shares or any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of ADSs (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of ADSs, outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

b) Reserved.

c) Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Ordinary Share Equivalents or rights to purchase shares, warrants, securities or other property pro rata to the record holders of any class of ADSs (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of ADSs acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of ADSs are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such ADSs as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

d) Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of Ordinary Shares or ADSs, by way of return of capital or otherwise (including, without limitation, any distribution of cash, shares or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of ADSs acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of Ordinary Shares or ADSs are to be determined for the participation in such Distribution (provided, however, that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any Ordinary Shares or ADSs as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

e) Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly, effects any sale, lease, exclusive license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Ordinary Shares (including any Ordinary Shares underlying the ADSs) are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Ordinary Shares or 50% or more of the voting power of the common equity of the Company (including any Ordinary Shares underlying the ADSs), (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Ordinary Shares or any compulsory share exchange pursuant to which the Ordinary Shares effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding Ordinary Shares (including any Ordinary Shares underlying the ADSs) or 50% or more of the voting power of the common equity of the Company (each a “Fundamental Transaction”), occurs or is consummated, then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share represented by each Warrant ADSs that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of capital stock of the successor or acquiring corporation or of the Company, if the Company is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of Warrant Shares represented by the Warrant ADSs for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one Ordinary Share (including any Warrant Shares underlying the ADSs), in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Ordinary Shares are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder’s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, however, that, if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of ADSs of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of ADSs are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of ADSs of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of ADSs will be deemed to have received common stock of the Successor Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. “Black Scholes Value” means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the “OV” function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of (a) 100% and (b) the greater of (1) the 30 day volatility, (2) the 100 day volatility or (3) the 365 day volatility, each of clauses (1)-(3) as obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price per ADS used in such calculation shall be the highest VWAP during the period beginning on the Trading Day immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder’s request pursuant to this Section 3(e) and (D) a remaining option time equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i) five Business Days of the Holder’s election and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant, a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Warrant Shares underlying the Warrant ADSs acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the Ordinary Shares underlying the Warrant ADSs pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term “Company” under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the “Company” shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(e) regardless of (i) whether the Company has sufficient authorized Ordinary Shares for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.

f) Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADS, as the case may be. For purposes of this Section 3, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (including Ordinary Shares underlying ADSs, but excluding treasury shares, if any) issued and outstanding.

g) Notice to Holder.

i. Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant ADSs and setting forth a brief statement of the facts requiring such adjustment.

ii. Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Ordinary Shares or ADSs, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Ordinary Shares or ADSs, (C) the Company shall authorize the granting to all holders of the Ordinary Shares or ADSs rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification of the Ordinary Shares or ADSs, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Ordinary Shares are converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Ordinary Shares or ADSs of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Ordinary Shares (including Warrant Shares underlying Warrant ADSs) of record shall be entitled to exchange their Ordinary Shares for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Report on Form 6-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

Section 4. Transfer of Warrant.

a) Transferability. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant ADSs without having a new Warrant issued.

b) New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and shall be identical with this Warrant except as to the number of Warrant ADSs issuable pursuant thereto.

c) Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

d) Transfer Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.

e) Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant ADSs issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Warrant ADSs or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.

Section 5. Miscellaneous.

a) No Rights as Shareholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant ADSs on a “cashless exercise” pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.

b) Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant ADSs, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

c) Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

d) Authorized Shares.

The Company covenants that, during the period the Warrant is outstanding, its directors will have authority to allot a sufficient number of shares to provide for the issuance of the Warrant ADSs and the underlying Ordinary Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the Warrant Shares needed for the Depositary to deliver the necessary Warrant ADSs upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares and Warrant ADSs and the underlying Ordinary Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the applicable Trading Market upon which the ADSs and Ordinary Shares may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant ADSs in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than any transfer restrictions and taxes in respect of any transfer occurring contemporaneously with such issue).

Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.

Before taking any action which would result in an adjustment in the number of Warrant ADSs for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.

e) Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.

f) Restrictions. The Holder acknowledges that the Warrant ADSs acquired upon the exercise of this Warrant, if the Warrant Shares are not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

g) Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

h) Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.

i) Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant ADSs, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any ADSs or Ordinary Shares or as a shareholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

j) Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

k) Depositary. For the avoidance of doubt, notwithstanding anything to the contrary contained herein, the Depositary’s rights and obligations with respect to the Company and the ADSs (including the Warrant ADSs) shall be as set forth in, and subject to, the terms and provisions of the deposit agreement among, inter alia, the Company and the Depositary and in no event shall this Warrant be deemed or construed to impose any additional obligations or liabilities on the Depositary, provided that this provision shall not limit in any respect the obligations of the Company under this Warrant.

l) Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant ADSs.

m) Company Acknowledgement. The Company acknowledges that the Company has received the aggregate par value amount of the Ordinary Shares underlying the Warrant ADSs upon exercise of this Warrant and the Company shall hold such aggregate nominal amount in trust and shall apply it as applicable in connection with exercises of this Warrant pursuant to Section 2(c) herein.

n) Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

o) Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.

p) Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

********************

(Signature Page Follows)

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

NOTICE OF EXERCISE

(1)  The undersigned hereby elects to purchase ________ Warrant ADSs of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

(2)  Payment shall take the form of (check applicable box):

☐ in lawful money of the United States; or

☐ if permitted, the cancellation of such number of Warrant ADSs as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the maximum number of Warrant ADSs purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).

(3)  Please register issue said Warrant ADSs in the name of the undersigned or in such other name as is specified below.

The Warrant ADSs shall be delivered to the following DWAC Account Number:

_______________________________

_______________________________

_______________________________

(4) Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the Securities Act of 1933, as amended.

[SIGNATURE OF HOLDER]

Name of Investing Entity: ______________________________________________________________________________

Signature of Authorized Signatory of Investing Entity: _____________________________________________________________________________

Name of Authorized Signatory: ______________________________________________________________________________

Title of Authorized Signatory: ______________________________________________________________________________

Date: ______________________________________________________________________________

EXHIBIT B

ASSIGNMENT FORM

(To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase Warrant ADSs.)

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

14